Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1992 3
1993 1
1994 2
1995 1
1996 3
1997 2
1998 1
1999 2
2000 2
2001 3
2002 1
2003 4
2004 3
2005 7
2006 3
2007 2
2008 1
2009 1
2010 1
2011 2
2014 3
2015 1
2016 2
2017 1
2018 1
2021 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for hazes b
Search for Hazevis B instead (1 results)
A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein.
Iyamu U, Vinals DF, Tornyigah B, Arango E, Bhat R, Adra TR, Grewal S, Martin K, Maestre A, Overduin M, Hazes B, Yanow SK. Iyamu U, et al. Among authors: hazes b. Front Cell Infect Microbiol. 2023 Jun 16;13:1202276. doi: 10.3389/fcimb.2023.1202276. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37396303 Free PMC article.
Specificity and function of activating Ly-49 receptors.
Kane KP, Silver ET, Hazes B. Kane KP, et al. Among authors: hazes b. Immunol Rev. 2001 Jun;181:104-14. doi: 10.1034/j.1600-065x.2001.1810108.x. Immunol Rev. 2001. PMID: 11513132 Review.
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Aman J, Duijvelaar E, Botros L, Kianzad A, Schippers JR, Smeele PJ, Azhang S, Bartelink IH, Bayoumy AA, Bet PM, Boersma W, Bonta PI, Boomars KAT, Bos LDJ, van Bragt JJMH, Braunstahl GJ, Celant LR, Eger KAB, Geelhoed JJM, van Glabbeek YLE, Grotjohan HP, Hagens LA, Happe CM, Hazes BD, Heunks LMA, van den Heuvel M, Hoefsloot W, Hoek RJA, Hoekstra R, Hofstee HMA, Juffermans NP, Kemper EM, Kos R, Kunst PWA, Lammers A, van der Lee I, van der Lee EL, Maitland-van der Zee AH, Mau Asam PFM, Mieras A, Muller M, Neefjes ECW, Nossent EJ, Oswald LMA, Overbeek MJ, Pamplona CC, Paternotte N, Pronk N, de Raaf MA, van Raaij BFM, Reijrink M, Schultz MJ, Serpa Neto A, Slob EMA, Smeenk FWJM, Smit MR, Smits AJ, Stalenhoef JE, Tuinman PR, Vanhove ALEM, Wessels JN, van Wezenbeek JCC, Vonk Noordegraaf A, de Man FS, Bogaard HJ. Aman J, et al. Among authors: hazes bd. Lancet Respir Med. 2021 Sep;9(9):957-968. doi: 10.1016/S2213-2600(21)00237-X. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147142 Free PMC article. Clinical Trial.
54 results